Alvotech (ALVO) Current Leases (2020 - 2026)
Alvotech (ALVO) posted Current Leases of $134.5 million for Q1 2026, down 2.52% on a QoQ basis from $138.0 million in Q4 2025, and up 12.9% year-over-year from $119.2 million in Q1 2025.
Alvotech (ALVO) Current Leases (2020 - 2026) Analysis & Trends
Alvotech's Current Leases history runs 7 years deep, the most recent figure standing at $134.5 million for Q1 2026.
- Quarterly Current Leases rose 12.9% year-over-year to $134.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $134.5 million (up 12.9% YoY) and the FY2025 annual result came in at $138.0 million, up 1350.33% from the prior year.
- Current Leases was $134.5 million for Q1 2026 at Alvotech, down from $138.0 million in the prior quarter.
- Across five years, Current Leases topped out at $144.5 million in Q3 2025 and bottomed at $9.5 million in Q4 2024.
- A 5-year average of $102.6 million and a median of $117.2 million in 2022 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2024 — Current Leases sank 90.99% — and 2025, when it surged 1350.33%.
- Alvotech's Current Leases stood at $35.4 million in 2022, then soared by 198.66% to $105.6 million in 2023, then sank by 90.99% to $9.5 million in 2024, then jumped by 1350.33% to $138.0 million in 2025, then decreased by 2.52% to $134.5 million in 2026.
- Business Quant data shows ALVO's Current Leases at $134.5 million in Q1 2026, $138.0 million in Q4 2025, and $144.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Alvotech | 935.87 Mn | 935.87 Mn | 5.09 Mn | 134.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 134.52 Mn |
| Dec 31, 2025 | 138.00 Mn |
| Sep 30, 2025 | 144.52 Mn |
| Jun 30, 2025 | 136.26 Mn |
| Mar 31, 2025 | 119.15 Mn |
| Dec 31, 2024 | 9.52 Mn |
| Sep 30, 2024 | 140.76 Mn |
| Jun 30, 2024 | 121.87 Mn |
| Mar 31, 2024 | 110.59 Mn |
| Dec 31, 2023 | 105.63 Mn |
| Jun 30, 2023 | 87.42 Mn |
| Mar 31, 2023 | 36.87 Mn |
| Dec 31, 2022 | 35.37 Mn |
| Jun 30, 2022 | 115.30 Mn |
| Dec 31, 2021 | 114.85 Mn |
| Dec 31, 2020 | 103.47 Mn |